Correlation Between Biosyent and Salesforce

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biosyent and Salesforce at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biosyent and Salesforce into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biosyent and SalesforceCom CDR, you can compare the effects of market volatilities on Biosyent and Salesforce and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biosyent with a short position of Salesforce. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biosyent and Salesforce.

Diversification Opportunities for Biosyent and Salesforce

0.64
  Correlation Coefficient

Poor diversification

The 3 months correlation between Biosyent and Salesforce is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Biosyent and SalesforceCom CDR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SalesforceCom CDR and Biosyent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biosyent are associated (or correlated) with Salesforce. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SalesforceCom CDR has no effect on the direction of Biosyent i.e., Biosyent and Salesforce go up and down completely randomly.

Pair Corralation between Biosyent and Salesforce

Given the investment horizon of 90 days Biosyent is expected to generate 0.56 times more return on investment than Salesforce. However, Biosyent is 1.8 times less risky than Salesforce. It trades about 0.14 of its potential returns per unit of risk. SalesforceCom CDR is currently generating about 0.02 per unit of risk. If you would invest  1,121  in Biosyent on September 23, 2024 and sell it today you would earn a total of  53.00  from holding Biosyent or generate 4.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Biosyent  vs.  SalesforceCom CDR

 Performance 
       Timeline  
Biosyent 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Biosyent are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Biosyent may actually be approaching a critical reversion point that can send shares even higher in January 2025.
SalesforceCom CDR 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in SalesforceCom CDR are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal basic indicators, Salesforce displayed solid returns over the last few months and may actually be approaching a breakup point.

Biosyent and Salesforce Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biosyent and Salesforce

The main advantage of trading using opposite Biosyent and Salesforce positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biosyent position performs unexpectedly, Salesforce can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Salesforce will offset losses from the drop in Salesforce's long position.
The idea behind Biosyent and SalesforceCom CDR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges